EW · Edwards Lifesciences Corp

$82.65 -1.17 (-1.40%) At close · Jul 24

Market Cap

$47.58B

575.80M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mr. Zovighian	CEO	$1,192,500	—	$7,167,024	$6,499,109	$2,406,537	$189,085	$17,454,255
Mr. Ullem	CFO	$807,898	—	$2,205,238	$1,999,726	$966,435	$71,257	$6,050,554
Mr. Wood	Former Corporate Vice President and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart	$635,919	—	$1,818,499	$1,648,710	$689,382	$61,829	$4,854,339
Mr. Chopra	Corporate Vice President, Transcatheter Mitral and Tricuspid Therapies	$671,042	—	$1,764,066	$1,375,784	$824,239	$60,611	$4,695,742
Mr. Bobo	Corporate Vice President, Strategy & Corporate Development Ms. Brüls	$759,783	—	$1,378,274	$1,249,829	$786,899	$48,580	$4,223,365

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mr. Zovighian	CEO	$1,133,846	—	$6,147,250	$5,748,762	$1,451,588	$98,028	$14,579,474
Ms. Szyman	Corporate Vice President, Critical Care	$490,769	$1,000	$4,249,116	—	$729,760	$39,327	$5,509,972
Mr. Ullem	CFO	$774,333	—	$2,032,263	$1,900,561	$525,938	$70,088	$5,303,183
Mr. Wood	Former Corporate Vice President and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart	$778,500	—	$1,601,038	$1,500,138	$656,370	$72,615	$4,608,661
Mr. Lemercier	Corporate Vice President	$587,253	—	$1,307,438	$1,224,484	$484,019	$165,070	$3,768,264
Mr. Bobo	Corporate Vice President, Strategy & Corporate Development Ms. Brüls	$737,054	$4,000	$1,229,450	$1,149,042	$576,131	$51,932	$3,747,609
Mr. Chopra	Corporate Vice President, Transcatheter Mitral and Tricuspid Therapies	$627,346	—	$1,284,500	$1,198,733	$556,133	$53,779	$3,720,491

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mr. Zovighian	CEO	$972,814	—	$5,099,085	$5,500,679	$1,234,207	$62,235	$12,869,020
Mr. Ullem	CFO	$743,421	—	$2,290,904	$2,308,575	$546,003	$60,250	$5,949,153
Mr. Wood	Former Corporate Vice President and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart	$763,227	—	$2,010,988	$1,898,467	$662,625	$59,727	$5,395,034
Ms. Szyman	Corporate Vice President, Critical Care	$672,728	$1,000	$1,479,357	$1,596,052	$552,420	$38,474	$4,340,031
Mr. Bobo	Corporate Vice President, Strategy & Corporate Development Ms. Brüls	$721,939	—	$1,453,964	$1,566,163	$504,060	$45,673	$4,291,799
Mr. Lemercier	Corporate Vice President	$741,355	—	$357,276	$384,317	$664,727	$214,152	$2,361,827
Mr. Mussallem	CEO	$604,321	—	$399,972	—	$602,640	$198,804	$1,805,737

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mr. Mussallem	CEO	$1,213,038	—	$5,583,038	$6,186,115	$869,400	$140,554	$13,992,145
Mr. Lemercier	Corporate Vice President	$665,635	—	$2,228,867	$2,446,507	$361,414	$208,689	$5,911,112
Mr. Ullem	CFO	$704,816	—	$1,314,025	$1,457,589	$319,643	$65,326	$3,861,399
Mr. Wood	Former Corporate Vice President and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart	$695,336	$2,000	$1,165,265	$1,293,106	$337,238	$65,876	$3,558,821
Mr. Zovighian	CEO	$641,922	—	$1,092,210	$1,209,870	$344,862	$49,563	$3,338,427
Mr. Bobo	Corporate Vice President, Strategy & Corporate Development Ms. Brüls	$692,745	$4,000	$992,873	$1,101,414	$351,624	$47,243	$3,189,899

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mr. Mussallem	CEO	$1,153,040	—	$5,230,175	$5,501,118	$1,581,770	$147,202	$13,613,305
Mr. Ullem	CFO	$664,688	—	$1,244,451	$1,306,053	$573,036	$81,175	$3,869,403
Mr. Wood	Former Corporate Vice President and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart	$658,063	$2,000	$1,114,085	$1,170,952	$567,418	$77,726	$3,590,244
Mr. Lemercier	Corporate Vice President	$654,236	—	$693,922	$728,243	$532,209	$239,517	$3,281,649
Mr. Bobo	Corporate Vice President, Strategy & Corporate Development Ms. Brüls	$658,091	—	$976,040	$1,026,875	$540,176	$64,329	$3,265,511

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mr. Mussallem	CEO	$1,121,299	—	$3,731,409	$4,232,880	$734,993	$230,352	$10,050,933
Mr. Lemercier	Corporate Vice President	$625,360	—	$604,174	$688,517	$254,746	$246,810	$4,344,915
Mr. Ullem	CFO	$647,079	$49,583	$1,091,084	$1,236,859	$262,500	$98,860	$3,385,965
Mr. Wood	Former Corporate Vice President and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart	$639,273	—	$968,369	$1,097,961	$273,000	$101,114	$3,079,717
Mr. Bobo	Corporate Vice President, Strategy & Corporate Development Ms. Brüls	$640,931	—	$856,555	$975,897	$252,000	$77,881	$2,803,264

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mr. Mussallem	CEO	$1,072,240	—	$3,641,664	$4,235,402	$2,381,117	$190,550	$11,520,973
Mr. Ullem	CFO	$619,760	—	$1,047,907	$1,098,595	$756,864	$47,945	$3,571,071
Mr. Lemercier	Corporate Vice President	$576,854	—	$546,270	$633,331	$555,287	$197,453	$3,313,960
Mr. Wood	Former Corporate Vice President and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart	$605,791	$4,000	$849,708	$988,184	$756,864	$88,736	$3,293,283
Mr. Bobo	Corporate Vice President, Strategy & Corporate Development Ms. Brüls	$615,455	$2,000	$807,687	$935,153	$671,600	$73,546	$3,105,441

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mr. Mussallem	CEO	$1,034,769	—	$3,409,941	$3,958,800	$1,668,227	$207,212	$10,278,949
Mr. Ullem	CFO	$593,628	—	$843,514	$975,537	$559,944	$49,207	$3,021,830
Mr. Wood	Former Corporate Vice President and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart	$574,430	$4,000	$804,231	$936,516	$507,683	$91,543	$2,918,403
Mr. Bobo	Corporate Vice President, Strategy & Corporate Development Ms. Brüls	$592,999	$4,000	$772,062	$891,964	$563,790	$78,584	$2,903,399

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mr. Mussallem	CEO	$995,385	—	$2,943,863	$3,409,180	$2,228,226	$176,099	$9,734,099
Mr. Ullem	CFO	$569,826	—	$855,664	$914,598	$800,400	$44,082	$3,184,570
Mr. Bobo	Corporate Vice President, Strategy & Corporate Development Ms. Brüls	$573,506	$2,000	$821,135	$881,474	$802,473	$68,501	$3,149,089
Mr. Wood	Former Corporate Vice President and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart	$550,506	$2,000	$821,135	$880,215	$780,318	$87,602	$3,121,776

Executive changes

Person	Role	Change	Effective	Filed
Theodora Mistras	Corporate Vice President, Chief Financial Officer	Appointed	2026-05-29	2026-05-04

Key facts CIK 1099800 CUSIP 28176E108 13F (30d) 377 filings 370 filers Visit website Investor relations